Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension
Clinical trial NCT06205628 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06205628
- Sponsor
- ADARx Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-21
- Primary completion
- 2026-07-31
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.